in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Saltigo signs contract manufacturing deal with Daiichi Sankyo
7:41 AM MDT | July 8, 2013 | Deepti Ramesh
Saltigo (Langenfeld, Germany), a wholly owned subsidiary of Lanxess, says it has signed an agreement with Daiichi Sankyo (Tokyo), one of the world's leading pharmaceutical companies, for providing contract manufacturing services. The agreement is associated with the preparation for commercializing one of Daiichi Sankyo’s novel drug pipeline projects, Saltigo says. Saltigo is a leading supplier in the field of custom synthesis, and the company belongs to the advanced intermediates segment of Lanxess, which had total sales of €1.67 billion in 2012 ($2.13...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee